18F-FDG PET/CT-based metabolic metrics in recurrent tumors of ovarian clear cell carcinoma and their prognostic implications.

MLA

Ye, Shuang, et al. “18F-FDG PET/CT-Based Metabolic Metrics in Recurrent Tumors of Ovarian Clear Cell Carcinoma and Their Prognostic Implications.” BMC Cancer, vol. 19, no. 1, Mar. 2019, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s12885-019-5441-7.

APA

Ye, S., Liu, S., Xiang, L., Wu, X., & Yang, H. (2019). 18F-FDG PET/CT-based metabolic metrics in recurrent tumors of ovarian clear cell carcinoma and their prognostic implications. BMC Cancer, 19(1), 1–7. https://doi.org/10.1186/s12885-019-5441-7

Chicago

Ye, Shuang, Shuai Liu, Libing Xiang, Xiaohua Wu, and Huijuan Yang. 2019. “18F-FDG PET/CT-Based Metabolic Metrics in Recurrent Tumors of Ovarian Clear Cell Carcinoma and Their Prognostic Implications.” BMC Cancer 19 (1): 1–7. doi:10.1186/s12885-019-5441-7.